Followers | 250 |
Posts | 160960 |
Boards Moderated | 18 |
Alias Born | 10/15/2000 |
![](https://investorshub.advfn.com/uicon/1908.png?cb=1672118147)
Thursday, April 10, 2008 10:11:19 AM
10:00a ET April 10, 2008 (Market Wire)
IDenta Corp. (PINKSHEETS: IDTA) announced today that it expects to soon sign a formal agreement with the French government to begin development of a totally new line of detection kits. The new products, as yet unnamed, will be used to identify precursor chemicals that are used to manufacture numerous illicit drugs such as methamphetamine, ecstasy, heroin and cocaine. The announcement comes after IDenta's recent trade mission to France where high level meetings were held with a special French commission, made up of high ranking law enforcement officials, investigating ways to curtail the production of illicit drugs by stopping the illegal import and shipment of precursor chemicals.
"Governments must monitor chemical imports and interrupt the delivery of these precursor ingredients before they are received by illegal drug manufacturers and traffickers," explained IDTA CEO Yaacov Shoham. "We are honored that the French have expressed their complete confidence in IDenta as the only organization that is fully qualified to develop these new detectors to their standards of accuracy and on-site reliability. I wish to thank Ibtec and Mr. Laurent Elbaze, who represent our company's products in France, for making this possible. We expect to announce a formal agreement in a very short time, and expect that these products could soon generate new large demands from countries around the world." (Not only from France)
Recently IDenta announced that the French government, through its representatives Ibtec, had selected IDenta drug identification products and the explosive identifiers for use throughout all of the country's law enforcement agencies. Orders for IDenta products in recent weeks have steadily increased from law enforcement agencies throughout that country.
About Precursors
Law enforcement agencies world-wide are keenly aware that chemical control is a crucial element to controlling the manufacture and distribution of illegal narcotics and synthetic substances. The International Office Of National Drug Control Policy (ONDCP), the U.S. Drug Enforcement Agency, and the U.S. Department of State are working with the major pseudoephedrine and Ephedrine producing/exporting countries of China, Germany, and India on a multi-faceted approach to address the issue of precursor diversion. In late February 2006, the DEA hosted a meeting in Hong Kong with Law Enforcement Officials from India, Germany, and several major pseudoephedrine and ephedrine importing countries to discuss pseudoephedrine and ephedrine diversion control issues. There was an overall agreement that more must be done internationally to control diversion and it was a significant first step in the process.
For further information see:
http://www.ondcp.gov/publications/international/factsht/eff_contr_precursr_chem.html
https://www.cia.gov/library/publications/the-world-factbook/fields/2086.html
About Identa
Since 2003, IDenta Corporation has become recognized as a worldwide leader in the development of proprietary on-site drug and explosive detection kits. IDenta develops, manufactures and distributes products for the both professional and civil markets that consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world. Information concerning IDenta's entire product line may be found at www.IDenta.biz.
Disclaimer
Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.
Contact: For Investor Relations, lobbying interests or information concerning IDenta's products internationally, contact: Yaacov Shoham IDenta Corp. CEO Tel: +972-52-6554487 fpi@drugsdetector.com For Investor Relations in the US, contact: Randy Jacobs Corporate Spokesman IDentaNews@sitcomllc.com 1-800-316-9437 For information about the Accutest® -- IDenta products in the US, please contact: Mr. Eyal Golan COO JANT PHARMACAL CORPORATION 16255 Ventura Blvd. #505 Encino, CA 91436 Toll Free: 800-676-5565 http://www.accutest.net
SOURCE: IDenta Corp.
mailto:fpi@drugsdetector.com mailto:IDentaNews@sitcomllc.com http://www.accutest.net
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM